Zanidatamab plus chemotherapy delays progression or death in patients with untreated locally advanced or metastatic gastroesophageal adenocarcinoma.

Investigators evaluated the benefit of leuprorelin immediately after radical prostatectomy for prostate cancer in patients with undetectable PSA levels.

In this study, researchers aimed to characterize cardiometabolic risk factors and cardiovascular disease incidence in racially and ethnically underrepresented women with breast cancer.

In May, the U.S. Food and Drug Administration (FDA) approved the first at-home cervical cancer screening tool, developed by Teal Health. The wand allows patients to collect a vaginal sample themselves ...

(HealthDay News) — Email communications can increase clinician engagement with prescription drug monitoring programs (PDMPs), according to a study published online Dec 19 in JAMA Health Forum.

Investigators explored the association between baseline patient-reported fatigue and the risk adverse events in cancer treatment trials.

New CDC guidelines categorize childhood vaccinations into routine, high-risk, and shared clinical decision-making tiers.

In this retrospective cohort analysis, researchers aimed to identify key predictors of trial enrollment among cancer patients.

Researchers compared the safety and efficacy of BrECADD vs eBEACOPP, a standard regimen, in the newly diagnosed, advanced-stage classical HL setting. Researchers determined the BrECADD combination ...

A survey of practices that treat AYA patients with cancer showed that almost half of them screen for financial hardship, but few offer cancer-specific navigation.

The Food and Drug Administration (FDA) has approved Rybrevant Faspro™, a subcutaneous (SC) formulation of amivantamab for all indications approved for the ...

A systematic review and meta-analysis compared the perioperative and oncologic outcomes of open versus minimally invasive inguinal lymphadenectomy during penile cancer surgery. A meta-analysis ...